E-health and m-health: using new technologies to respond to drug problems. by Blankers, Matthijs & Mujcic, Ajla
Authors
M. Blankers and A. Mujcic
2017
E-health and m-health:  
using new technologies  
to respond to drug problems
Background paper commissioned by the EMCDDA for 
Health and social responses to drug problems: a European guide
 E-health and m-health: using new technologies to respond to drug problems 
 
Matthijs Blankers, PhD 
Ajla Mujcic, MSc 
 
Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Department of Drug 
Monitoring & Policy, Da Costakade 45, 3521 VS Utrecht, The Netherlands 
 
Both authors contributed equally to this paper. 
 
Key words: e-health; m-health; substance use problems; Europe 
 
October 2017 
Summary 
This paper presents a definition of e-health and m-heath tools to address substance use problems, 
and a taxonomy to describe such tools systematically. A number of examples of e-health tools that 
are currently being used in Europe for prevention, treatment and harm reduction of substance use 
are presented, based on a selective literature search. Recent reviews and other studies on the 
effectiveness of e-health tools are discussed. Most of the available research has focused on the 
reduction of cannabis use, alcohol moderation and smoking cessation, and to a lesser extent on 
reducing use of stimulants and opioids. The paper concludes with a number of future challenges for 
the wider implementation of e-health and m-health for substance use problems in Europe.  
 
 
 
This paper was commissioned by the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) to provide background information to inform and contribute to the drafting of Health and 
social responses to drug problems: a European guide.  
This background paper was produced under contract CT.16.SDI.0145.1.0 and we are grateful for the 
valuable contribution of the authors. The paper has been cited within Health and social responses to 
drug problems and is also being made available online for those who would like further information 
on the topic. However, the views, interpretations and conclusions set out in this publication are 
those of the authors and are not necessarily those of the EMCDDA or its partners, any EU Member 
State or any agency or institution of the European Union.  
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Introduction 
Advances in new technologies and the ubiquitous availability of the internet have provided many 
new possibilities for addressing a wide array of health problems, including substance use problems. 
The use of digital (computer-based) technologies for health is referred to as ‘e-health’ (WHO, 2016a). 
Examples of health practices supported by e-health are the treatment of patients (via internet or 
computer-based interventions for substance use disorders — SUDs), education of SUD treatment 
professionals (using e-learning modules on therapeutic techniques) and patient monitoring (e.g. 
digitised substance use diaries to monitor substance use behaviour as part of SUD treatment). 
Mobile digital technologies to support health practices are referred to as ‘m-health’. M-health is an 
abbreviation of mobile health, and encompasses all programmes accessible through mobile devices 
such as smartphones and tablets (WHO, 2016b). M-health is conceptually nested within e-health, in 
the sense that e-health is an overarching term for digital health technology, including m-health. 
Therefore, wherever e-health is mentioned in this paper, m-health is implicitly included as well. 
There are a number of perceived advantages to the use of e-health. The most prominent include the 
possibility of enhancing access to evidence-based treatment and information, improving the 
implementation of interventions among new target populations and tailoring treatment or 
information to specific populations and individual needs (see, for example, Shoemaker and Hilty, 
2016). The perceived anonymity of e-health interventions could make it easier to reach populations 
that fear stigmatisation (e.g. illicit drug users, high-functioning alcohol misusers; see Postel et al., 
2005). Another possible advantage of e-health is the increased patient-centredness of interventions; 
the patient can decide to work with an e-health intervention at any time of day, instead of having to 
wait until his/her next appointment with a professional — hence fostering self-management. In 
addition, e-health offers possibilities for interactive contact between providers and users, and 
between professionals and patients. From a healthcare management perspective, the accumulating 
evidence for the cost-effectiveness of e-health interventions (Donker et al., 2015) is worth 
mentioning. 
Despite these advantages, the majority of healthcare professionals state that e-health applications 
are poorly or not at all implemented in their healthcare setting (Murray et al., 2011). Challenges to 
the uptake of e-health include the fact that it is less well able to reach populations with lower 
computer/smartphone ownership rates (digital divide) — although this challenge may be addressed 
in part by m-health, given the accumulating worldwide smartphone penetration rates (Pewglobal, 
2016). E-health applications may often also be less suitable for people who have reading problems, 
because of its (often) textual nature. 
To stimulate the understanding and use of e-health in responding to drug problems in Europe, in this 
paper we will address the following questions: (1) How can e-health and m-health interventions be 
comprehensively classified and described?; (2) How is e-health currently used to respond to drug use 
problems in Europe?; and (3) What is known about the effectiveness of e-health interventions for 
drug use problems?  
 
Method 
A selective literature search was carried out. Recent and well-known taxonomies for e-health 
interventions are presented, which can serve as starting points either to describe and evaluate 
existing e-health interventions and tools or to develop new ones. Examples of European e-health 
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interventions for drug problems give an indication of the diversity of target groups, modes of 
delivery, settings and intervention types (harm reduction, treatment and prevention). A 
comprehensive review of the effectiveness of e-health for drug problems based on recent systematic 
reviews is presented. 
Taxonomy of e-health interventions 
E-health can target a broad range of substance use behaviours and is applied in various preventive, 
curative treatment and harm reduction interventions. As the use of e-health interventions continues 
to evolve, interventions become increasingly diverse in content, target, intensity and type of 
technology. Standardised descriptions of behaviour change techniques enhance specification, 
evaluation and implementation of internet-based interventions (see Hekler et al., 2016). There are a 
number of taxonomies, frameworks and guidelines that can be used to categorise existing e-health 
interventions, or which can be helpful in the development of new interventions. 
Litvin et al. (2013) proposed a framework for e-health interventions specifically designed for SUDs. 
This framework helps to evaluate and develop e-health interventions for SUDs by providing choices 
in four main categories: accessibility (setting/location, type of technology), usage (duration, 
exposure, attrition), human contact (asynchronous, synchronous, clinician, peers) and intervention 
content (static, dynamic, tailoring, theory/orientation).  
A recent study validated a comprehensive list of e-health intervention characteristics using expert 
opinions, with the aim of creating a classification system in which e-health intervention 
characteristics can be described consistently and comprehensively (Bewick et al., 2017). Ten 
characteristics were considered of key importance to describe e-health interventions. Six of these 
were descriptive aspects on which e-health interventions may vary: behavioural target, target 
population, underpinning behaviour change technique, type of technology used (e.g. mobile 
technology), intended setting for the intervention and whether or not there are costs associated with 
the intervention for the end user. Four characteristics were quantifiable: the intended duration of 
the intervention (single session or multiple sessions over time), the extent to which the intervention 
content was informed by theory (e.g. self-affirmation theory, theory of planned behaviour), the 
extent to which contents of the intervention are tailored to specific needs of the end user and the 
extent to which the intervention includes counsellor involvement. The list is intended as a tool to 
describe existing e-health interventions and to guide discussion during the development of new e-
health tools. In addition, it provides a perspective on the various dimensions on which e-health 
interventions may vary. 
A more extensive taxonomy has been developed by Michie et al. (2013). They developed a 
hierarchical taxonomy consisting of 93 behaviour change techniques (BCTs) to standardise 
descriptions of active intervention components, through several international consensus exercises. 
Each BCT is an irreducible, observable and replicable component that can be compared across 
studies. The BCTs are clustered into 16 groups (Table 1). The left-hand column of Table 1 presents 
the 16 groups of BCTs, while the right-hand column gives an example from each of the 16 groups. An 
intervention may contain modules corresponding to one or more of the BCTs. Online training 
(www.bct-taxonomy.com) and workshops (http://www.ucl.ac.uk/behaviour-change) are 
recommended to gain familiarity with this taxonomy and to use it accurately in the development and 
evaluation of complex behaviour change interventions. 
Although this taxonomy system is not specifically developed for e-health interventions, its focus on 
identifying effective behaviour change elements makes it very relevant for e-health intervention 
developers. 
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In addition to taxonomies focusing on the contents of interventions, professionals who want to 
develop e-health interventions could consult the guideline developed within the Click for Support 
network, an EU-funded international project (LWL, 2015). One of the main objectives of this project 
was to develop a guideline for the development and implementation of effective web-based 
interventions for young people using illicit drugs. The guideline focuses on four themes: (1) aspects 
to consider before starting the development of an e-health intervention (such as exploring the needs 
of the target group prior to development, e.g. through focus groups); (2) technical aspects of e-
health development (e.g. data security and user anonymity — application of European Union (EU) 
regulations on data protection, as well as relevant national regulations); (3) the appropriate use of 
interactive elements (e.g. to be more attractive to young people, include fun elements such as apps 
or games); and (4) specific aspects to extend the reach to young drug users (e.g. involve the target 
group in promoting the website). The first version of the guidelines was launched in 2015 (LWL, 
2015); an update is planned in 2018. 
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Table 1. Groups with example behaviour change techniques (BCTs) in BCT Taxonomy v1 (Michie et 
al., 2013; see also http://www.bct-taxonomy.com) 
Behaviour 
change 
technique 
number 
Group of behaviour 
change techniques 
Example intervention module Definition of example behaviour change 
technique 
1 Goals and planning Behavioural contract Create a written specification of the 
behaviour to be performed, agreed by the 
person and witnessed by another 
2 Feedback and monitoring Self-monitoring of behaviour Establish a method for the person to monitor 
and record their behaviour(s) as part of a 
behaviour change strategy 
3 Social support Social support (practical) Advise on, arrange or provide practical help 
for performance of the behaviour 
4 Shaping knowledge Instruction on how to perform 
the behaviour 
Advise or agree on how to perform the 
behaviour 
5 Natural consequences Information about health 
consequences 
Provide information about health 
consequences of performing the behaviour 
6 Comparison of behaviour Demonstration of the behaviour Provide an observable sample of the 
performance of the behaviour, directly in 
person or indirectly 
7 Associations Prompts/cues Introduce or define environmental or social 
stimulus with the purpose of prompting or 
cueing the behaviour. The prompt or cue 
would normally occur at the place of the 
performance 
8 Repetition and 
substitution 
Behaviour practice/rehearsal Prompt practice or rehearsal of the 
performance of the behaviour one or more 
times, in a context or at a time when the 
performance may not be necessary, to 
increase habit and skill 
9 Comparison of outcomes Pros and cons Advise the person to identify and compare 
reasons for wanting (pros) and not wanting to 
(cons) change the behaviour 
10 Reward and threat Material incentive (behaviour) State that money, vouchers or other valued 
objects will be delivered if and only if there 
has been effort and/or progress in 
performing the behaviour 
11 Regulation Pharmacological support Provide, or encourage the use of or 
adherence to, drugs to facilitate behaviour 
change 
12 Antecedents Distraction Advise or arrange to use an alternative focus 
for attention to avoid triggers for unwanted 
behaviour 
13 Identity Identification of self as a role 
model 
State that one’s own behaviour may be an 
example to others 
14 Scheduled consequences Behaviour cost Arrange for withdrawal of something valued 
if and only if an unwanted behaviour is 
performed 
15 Self-belief Self-talk Prompt positive self-talk (aloud or silently) 
before and during the behaviour 
16 Covert learning Imaginary reward Advise the person to imagine performing the 
wanted behaviour in a real-life situation 
followed by imagining a pleasant 
consequence 
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Examples of e-health applications for substance use in Europe 
In this section, a number of examples of e-health and m-health applications to address various 
aspects of substance use will be presented. These are selected examples of applications used in an 
indicated prevention context, in the context of substance use treatment, as well as examples of harm 
reduction tools, to give an indication of the types of e-health tools that have been used and 
developed over the past years. 
Prevention 
Quit the Shit (QTS) is a German online cannabis withdrawal programme developed for adolescents 
aged 15-17 years who want to reduce or quit their cannabis use (Tossmann et al., 2011). In an 
interactive diary, users document and monitor their drug use daily, over a period of 50 days. In 
addition, a counselling team provides them with tips and personalised feedback at least once a week, 
to support users in achieving their personal goals (see Figure 1). More than 90 % of QTS users 
indicate that the information provided to control cannabis consumption is comprehensible and that 
the website is easy to use. The same is true of their experiences with their contact with the 
counselling team. The user feedback indicates that the central programme components — the diary 
and the diary comments made by the counselling team — are highly accepted and represent an 
efficient aid in reducing cannabis consumption. These positive assessments of individual programme 
elements add up to a high recommendation rate: 85 % of the participants indicates that they would 
recommend QTS to others. Three months after registration, users of QTS show a significantly greater 
reduction in consumption measures than a waiting list control group. The between-group effect sizes 
are moderate to large (EMCDDA, 2015). 
 
 
Figure 1. Screenshot of online cannabis withdrawal programme ‘Quit the Shit’. 
Source: www.quit-the-shit.net  
 
Païhdelinkki.fi is a Finnish information service and web portal for substance users, their families and 
their friends. It provides information and self-test modules to self-assess the severity of various 
substance use problems, depression symptoms and/or behavioural addictions. Self-help guides are 
available for alcohol misuse, gaming, use of amphetamines, cannabis use and general substance use 
(see Figure 2). Web service users can communicate with each other on a forum. There is also an 
opportunity to ask trained professionals questions on substance use. 
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Figure 2. Screenshot of Finnish online information service on drug use and cessation of drug use 
(translated into English from Finnish).  
Source: https://www.paihdelinkki.fi/ 
 
Mielenterveystalo.fi (English: ‘Mentalhub.fi’) is a Finnish mental health website. Mielenterveystalo.fi 
includes a module on excessive alcohol use, in addition to modules on common mental health 
problems such as depression and anxiety. Like Paihdelinkki, it offers information and self-tests to 
both website users and their families. It provides a step-by-step approach to addressing alcohol 
misuse and other health problems, and includes paper-and-pencil forms which can be printed and 
used (see Figure 3a). Mielterveystalo.fi also offers a blended e-health treatment programme in which 
a web therapist guides users via email through the various exercises. In addition to exercises and 
information, three fictional ‘patients’ are followed and their progress is discussed in the blended 
programme. The website also teaches how to tailor information to different age groups (see Figure 
3b and 3c). Special sections of the website have been developed for young adolescents and for 
children. Here, they can access tailored self-tests, self-help information and information on 
professional help.  
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Figure 3a. Screenshot of self-help module ‘Drink management’ on the Finnish mental health service 
website Mielenterveystalo (translated into English from Finnish). 
Source: https://www.mielenterveystalo.fi 
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Figure 3b. Screenshot of the section for adolescents and teens on the Finnish mental health service 
website Mielenterveystalo (translated into English from Finnish). 
Source: https://www.mielenterveystalo.fi/nuoret/ 
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Figure 3c. Screenshot of the section for children on the Finnish mental health service website 
Mielenterveystalo (in Finnish). 
Source: https://www.mielenterveystalo.fi/nuoret/lapset/ 
 
Treatment 
The Dutch substance abuse treatment centre Jellinek has developed a number of e-health 
interventions for the treatment of substance use disorders. Interested individuals can fill out an 
online screening assessment to assess their level of risky substance use behaviour. Based on this 
assessment, they may be referred to various e-health treatment options. Available e-health options 
are fully self-guided online interventions — similar to QTS — for people with risky substance use. For 
those who meet the criteria for a substance use disorder diagnosis, a ‘blended’ programme called 
MijnJellinek (‘My Jellinek’) combines an e-health intervention with face-to-face contacts when a 
therapist is available (Figure 4). This blended programme has been developed to provide therapeutic 
support for quitting tobacco smoking, alcohol use, cannabis use, cocaine use, other illicit drug use 
and gambling. All MijnJellinek e-health interventions are based on cognitive behavioural therapy 
(CBT). In this e-health intervention, patients can read or watch videos on substance use (disorders) 
and associated risks, and complete/undertake their homework assignments, which are based on CBT 
treatment manuals. The e-health intervention also facilitates secured online messaging between 
patients and their therapist. Alongside the use of MijnJellinek, patients have 3-10 face-to-face 
sessions with their therapist (Jellinek, 2014).  
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Figure 4. Screenshot of Dutch blended e-health treatment programme MijnJellinek. 
Source: Jellinek.nl 
 
ACHESS (Addiction Comprehensive Health Enhancement Support System) is an American m-health 
app shown to have a positive effect on problematic alcohol use (Gustafson et al., 2014). This app 
provides continuing care after residential treatment for alcohol use disorders, to prevent relapse 
(Figure 5). Among other things, it offers information and the possibility to engage in discussion 
groups or to communicate with experts. The app also features global positioning system (GPS) 
technology, tracking when a user nears a high-risk location where he or she usually consumes or buys 
alcohol. On such an occasion, the user receives automated support to prevent relapse (McTavish et 
al., 2012). 
 
 
Figure 5. Screenshot of the mobile phone app ACHESS (Addiction Comprehensive Health 
Enhancement Support System).  
Source: http://www.chessmobilehealth.com 
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Harm reduction  
Red Alert is a Dutch m-health app developed by the Trimbos Institute in 2016. The primary aim of 
Red Alert is to warn substance users about extremely high-dose or contaminated ecstasy tablets that 
may be circulating in their area. Upon starting the app, users receive warnings about contaminated 
substances that may be circulating, and they can quickly access up-to-date general information on 
these and other substances. The app also provides information on drug-testing facilities (Figure 6). In 
addition, national warnings (called Red Alerts) on extremely dangerous drugs circulating in the 
Netherlands can quickly be conveyed to all users through push notifications: everyone who has the 
app installed on their smartphone or tablet will receive this notification (Trimbos Institute, 2016). 
 
 
Figure 6. Screenshot of the Dutch harm reduction app Red Alert.  
Source: drugsredalert.nl 
 
The Overdose Risk Information Tool (ORION) is an e-health decision support tool for individuals who 
are at high risk of experiencing a drug overdose. Through a number of questions this tool calculates 
an overdose risk estimate of 0 (lowest) to 100 (highest), and presents this risk estimate in a visually 
attractive way (Figure 7). An example question is: ‘Have you ever used drugs (including alcohol) when 
you were alone?’. After answering all questions and reviewing the risk assessment, users can change 
their answers to the questions to see how it affects their risk assessment. The aim of the tool is to 
facilitate discussion on overdose risk management between substance users and their doctors. A 
pilot implementation of this e-health tool was successfully carried out in multiple clinical treatment 
settings for substance use in four EU countries (Humphris et al., 2013). 
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Figure 7. Overdose risk feedback screenshot from the ORION decision support tool. 
Source: Humphris et al. (2013). 
 
A somewhat similar risk assessment tool has been developed for binge drinking: Digital-Alcohol Risk 
Alertness Notifying Network for Adolescents and Young Adults (D-ARIANNA). This m-health app 
presents the user with a number of questions, then calculates the estimated risk of binge drinking 
based on identified risk factors. The estimated risk is displayed as a risk percentage (Figure 8). A pre-
/post-test study found that users engage less in binge drinking in the two weeks following use of D-
ARIANNA (Carrà et al., 2016). 
 
 
Figure 8. Screenshot of estimated risk percentage for binge drinking from the D-ARIANNA app.  
Source: Google Play Store: http://archive.is/ZQi21. 
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New developments 
Virtual reality (VR) has been explored as a new technology in assessment and cue exposure therapy 
for substance use disorders (Hone-Blanchet et al., 2014). Wearing a head-mounted display, users find 
themselves in a computer-generated three-dimensional (3D) environment that they can move 
around in and interact with. Through VR, social interactions and substance-related cues that are 
unique to users can be simulated in a representation of their natural environment (i.e. a bar), instead 
of presenting these cues detached from that environment. Hence, VR simulates a craving-inducing 
yet safe environment to practise new (refusal) skills. It must be noted that VR has not yet been 
extensively compared with other treatment conditions and that little is known about its long-term 
effects on craving (Hone-Blanchet et al., 2014). 
 
Cognitive bias modification (CBM) has been considered a promising line of work in recent years, 
including in the field of substance use disorders. CBM interventions target cognitive processes 
directly, and in particular attentional biases and approach biases. These interventions often consist 
of repeating a set of cognitive tasks several times. A recent review concludes that there is little 
evidence for the effectiveness of (internet-based) CBM for SUDs, and that interventions need further 
development to achieve clinically relevant change in cognitive biases and substance use (Cristea et 
al., 2016). The inclusion in the Cristea et al. (2016) review of studies whose participants who were 
not motivated to change their behaviour may have attenuated the potential effects of CBM (Wiers, 
2016), but clearly more research is needed to justify widespread clinical applications of CBM for 
substance use problems.  
Effectiveness of e-health interventions 
Most of the evidence on the effectiveness of e-health interventions for substance use problems has 
been collected for interventions that aim to reduce cannabis use (Tait et al., 2013; Hoch et al., 2016), 
alcohol use (Sundström et al., 2016) and smoking cessation (e.g. Civljak et al., 2013), and to a lesser 
extent to reduce stimulant and opioid use (Boumparis et al., 2017). In this section we summarise 
findings regarding effectiveness. If available, we also report evidence on factors that influence the 
effectiveness of these interventions (e.g. therapist involvement). 
 
Cannabis 
A number of studies have recently focused on the effectiveness of e-health interventions for 
cannabis use. We discuss two recent systematic reviews with meta-analyses. These two systematic 
reviews report small effects of e-health interventions on cannabis use, and provide little indication of 
factors that influence the effectiveness of the interventions. 
Hoch et al. (2016) conducted a meta-analysis of four studies, involving a total of 9 128 participants, 
conducted outside clinical settings in Europe, the US, Australia and Oceania. The studies compared 
online motivational interviewing and CBT e-health interventions with a control condition, which was 
either a waiting list control condition or another therapist-delivered intervention. The meta-analysis 
revealed a small positive effect at three-month follow-up in favour of cannabis e-health interventions 
(effect size: Hedges’ g = 0.11). 
Tait et al. (2013) carried out a systematic review and meta-analysis of 10 randomised trials of e-
health prevention and treatment interventions conducted in Germany, the US, Australia and Canada. 
The studies included a total of 4 125 participants and compared the effect over time of the 
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intervention or the control condition on the frequency of cannabis use. A small but significant post-
treatment effect was found overall (Hedges’ g = 0.16; 95 % confidence interval 0.09 to 0.22; 
p < 0.001) in favour of the cannabis e-health interventions. In a post hoc analysis the authors 
evaluated a number of factors that could potentially influence the effect sizes. However, in these 
subgroup analyses they did not find any significant moderating role for key factors such as type of 
control (active, waiting list), age group (11-16, 17+ years), gender, type of intervention (prevention or 
treatment), guided versus unguided programmes, mode of delivery (internet, computer), individual 
versus family dyad or intervention delivery setting (home, research setting). In addition, neither 
number of sessions nor time to follow-up was found to have any significant moderation effect. 
A recent study by Schaub et al. (2015a) compared the effectiveness of online self-help interventions, 
with or without chat with a trained counsellor, and a waiting list control condition in reducing 
cannabis use. In this study, significant differences in cannabis use were found between the 
conditions self-help with chat counselling and waiting list, as well as between self-help with chat and 
self-help without chat, but no difference was found between self-help without chat and the waiting 
list condition. Clearly this indicates that guidance from a counsellor trained in e-health interventions 
for cannabis use can have a positive effect on cannabis use outcomes.  
 
Stimulants and opioids 
Boumparis et al. (2017) published a meta-analysis on the effectiveness of e-health interventions 
compared with control conditions in reducing the use of opioids, cocaine and amphetamines. The 
meta-analysis included 17 studies with a total of 2 836 adult participants. The results showed that e-
health interventions led to a significant decrease in opioid drug use (four studies) and any illicit drug 
use (nine studies) after treatment. In the case of e-health interventions specifically aimed at reducing 
the use of stimulants, the decrease in use after treatment was small and non-significant. Overall, no 
association was found between duration of the intervention, or number of sessions, and effect sizes.  
An ongoing European randomised control trial (RCT) will test the effectiveness of a web-based 
intervention to reduce cocaine use (Schaub et al., 2015b). This three-arm RCT will compare the 
effectiveness of a self-help web-based intervention, with and without chat counselling with a 
healthcare professional, and a waiting list control condition. The web-based intervention is based on 
CBT, behavioural self-management, motivational enhancement and social problem solving. The 
results will shed light on whether or not a therapeutic alliance between a therapist and cocaine users 
can be established through the internet, and whether or not this has an effect on treatment 
outcomes. 
 
Alcohol 
A recent review of 14 review studies on e-health interventions to reduce alcohol use provides an 
overview of knowledge and knowledge gaps in the field (Sundström et al., 2016). In this review, 
available evidence on effectiveness is integrated, and the impact of moderators of effectiveness such 
as the therapeutic orientation, length of intervention and guidance is explored. Across the included 
reviews, it was generally reported that e-health alcohol interventions were effective in reducing 
alcohol consumption, with mostly small effect sizes. It was also found that longer, multisession, 
interventions were more effective than shorter or single-session interventions. Evidence on the 
association between therapeutic orientation and alcohol use reduction, and between intervention 
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guidance and alcohol use reduction, was found to be limited, as the number of studies addressing 
these themes is low. All in all, for alcohol there is a relatively strong evidence base supporting the 
effectiveness of e-health interventions. Longer, more intensive interventions do lead to better 
outcomes than brief interventions. 
 
Tobacco 
A number of e-health interventions that aim to promote tobacco smoking cessation have been 
developed and tested in RCTs. CBT and associated intervention approaches such as acceptance and 
commitment therapy, together with techniques stemming from motivational interviewing, are the 
dominant therapeutic approaches (Blankers et al., 2016). Three meta-analyses (Myung et al., 2009; 
Shahab and McEwan., 2009; Rooke et al., 2010) and a Cochrane review (Civljak et al., 2013) report 
that guided and unguided e-health interventions for smoking cessation are probably more effective 
in helping people quit smoking than waiting list controls and information-only interventions. 
However, a substantial minority of the studies failed to find clinically relevant effects, and many of 
the other studies found only small positive effects. A recent meta-analysis on the effectiveness of 
(text-based) e-health interventions for smoking cessation versus smoking assessment or non-
electronic self-help materials also reports relatively small but statistically significant positive effects 
of e-health interventions, with no indication of relevant effect moderators (Crocamo et al., 2017). 
However, if large numbers of smokers can be reached using e-health interventions, even a small 
effect can make a considerable public health impact. With regard to effect moderators, some authors 
have reported that only e-health interventions that were offered to tobacco smokers who are 
motivated to quit showed positive results (Shahab et al., 2009).  
 
Conclusions and future directions 
In this paper, we have presented definitions of e-health and m-health, and we have presented the 
various aspects that characterise e-health and m-health tools and interventions. Examples have been 
presented of the various forms in which e- and m-health interventions are currently used for 
prevention, treatment and harm reduction related to drug use. Regarding the effectiveness of the 
interventions, there is relatively strong evidence for the effects of e-health interventions aiming at 
the reduction of cannabis use, alcohol use and tobacco use, and some evidence for the reduction of 
opioid use. However, there is no compelling evidence to support the use of e-health for the 
reduction of stimulants use. There is a clear lack of research on the effectiveness of e-health 
applications for harm reduction purposes. This does not mean that the latter e-health applications 
are ineffective, however, or that they should not be used, but more research in these areas is 
needed. An opportunity for the coming years is to build a convincing evidence base for e-health and 
m-health tools that address understudied substances, as well as for harm reduction e-health 
interventions. 
Another important challenge is to increase the use of existing evidence-based e-health/m-health 
tools and interventions — especially by hard-to-reach target populations, such as injecting drug users 
or drug-using immigrants. A first step may be to make sure that effective tools are kept available 
longer than is often currently the case. What frequently happens currently is that interventions are 
developed for (research) projects, and become unavailable after the project is finished, due to a lack 
of funding to cover the running costs of these interventions. As those yearly running costs are often 
only a fraction of the costs of the research and development project for which they were developed, 
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finding a solution to keep effective e-health tools available to the wider public after completion of 
those projects would be a very cost-effective approach to improving the value of e-health research 
and development projects. 
The use of existing effective and successful e-health interventions could be further fostered by 
translating e-health tools developed in one language into other European languages. There is 
evidence which shows that the translation of effective e-health interventions is a cost-effective way 
to create new treatment possibilities (Lintvedt et al., 2013). Funding the translation of existing e-
health tools from EU Member States to make them available in all other EU Member States could 
greatly advance the further implementation of e-health for substance use problems. Advances in 
technology have opened up significant possibilities for continuous, real-time data collection and 
feedback from a variety of sources (i.e. smartphones, social media, sensors, self-reporting). It has 
been suggested that a new approach to processing these data, involving the collection of relevant 
data, followed by the development of computational models, would reduce researchers' reliance on 
the need to test a particular theory (Spruijt-Metz et al., 2015). 
A theme that has not been addressed thus far in this paper has to do with quality management and 
security of e-health tools. E-health tools used by people who consume illegal substances may contain 
very sensitive data, which may pose a risk to the end user if handled in an indiscreet manner. EU-
level regulations and good practices regarding data security for e-health interventions targeting 
substance users should be strictly implemented, and this implementation should be monitored.  
All in all, e-health and m-health tools form a relevant and promising innovation in addressing 
substance use problems in Europe. 
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